Paper32052028
Wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase, induces accumulation of DNA double-strand breaks.
Ihara M and 3 others. J Radiat Res, 2020. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase, induces accumulation of DNA double-strand breaks. Papers, record 32052028. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32052028
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase, induces accumulation of DNA double-strand breaks.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA Breaks, Double-Stranded | Major topic |
| Phosphatidylinositol 3-Kinase | Major topic |
| Protein Kinase Inhibitors | Major topic |
| Wortmannin | Major topic |
| Animals | |
| Cell Line | |
| Cell Survival | |
| Histones | |
| Humans | |
| Phosphorylation | |
| Radiation Tolerance |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9766667 | Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin. | Cancer Res | 1998 | https://conductscience.org/library/papers/9766667 | PubMed |
| 2 | 2215662 | The scid mutation in mice causes a general defect in DNA repair. | Nature | 1990 | https://conductscience.org/library/papers/2215662 | PubMed |
| 3 | 19576233 | DNA double-strand breaks: their production, recognition, and repair in eukaryotes. | Mutat Res | 2009 | https://conductscience.org/library/papers/19576233 | PubMed |
| 4 | 11242102 | DNA double-strand breaks: signaling, repair and the cancer connection. | Nat Genet | 2001 | https://conductscience.org/library/papers/11242102 | PubMed |
| 5 | 12410360 | Wortmannin inhibits growth of human non-small-cell lung cancer in vitro and in vivo. | Langenbecks Arch Surg | 2002 | https://conductscience.org/library/papers/12410360 | PubMed |
| 6 | 16828758 | Quantitative measurement of hydroxyl radical induced DNA double-strand breaks and the effect of N-acetyl-L-cysteine. | FEBS Lett | 2006 | https://conductscience.org/library/papers/16828758 | PubMed |
| 7 | 18610740 | Gamma-H2AX - a novel biomarker for DNA double-strand breaks. | In Vivo | 2008 | https://conductscience.org/library/papers/18610740 | PubMed |
| 8 | 9815794 | Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay. | Clin Cancer Res | 1997 | https://conductscience.org/library/papers/9815794 | PubMed |
| 9 | 7889575 | Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. | Cell | 1995 | https://conductscience.org/library/papers/7889575 | PubMed |
| 10 | 24000320 | DNA double strand break repair via non-homologous end-joining. | Transl Cancer Res | 2013 | https://conductscience.org/library/papers/24000320 | PubMed |
| 11 | 6823332 | A severe combined immunodeficiency mutation in the mouse. | Nature | 1983 | https://conductscience.org/library/papers/6823332 | PubMed |
| 12 | 11571274 | ATM phosphorylates histone H2AX in response to DNA double-strand breaks. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11571274 | PubMed |
| 13 | 8542574 | The phosphatidylinositol 3-kinase inhibitor wortmannin sensitizes murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage. | Cancer Res | 1996 | https://conductscience.org/library/papers/8542574 | PubMed |
| 14 | 25104768 | Sources of DNA double-strand breaks and models of recombinational DNA repair. | Cold Spring Harb Perspect Biol | 2014 | https://conductscience.org/library/papers/25104768 | PubMed |
| 15 | 6828386 | Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. | Nucleic Acids Res | 1983 | https://conductscience.org/library/papers/6828386 | PubMed |
| 16 | 27884168 | Ataxia telangiectasia: a review. | Orphanet J Rare Dis | 2016 | https://conductscience.org/library/papers/27884168 | PubMed |
| 17 | 8162590 | Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. | Cancer Res | 1994 | https://conductscience.org/library/papers/8162590 | PubMed |
| 18 | 7671312 | DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. | Cell | 1995 | https://conductscience.org/library/papers/7671312 | PubMed |
| 19 | 22569912 | Role of non-homologous end joining in V(D)J recombination. | Immunol Res | 2012 | https://conductscience.org/library/papers/22569912 | PubMed |
| 20 | 12792649 | Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. | Nat Cell Biol | 2003 | https://conductscience.org/library/papers/12792649 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42984918 | Targeting ATM Kinase in Cancer-A Comprehensive Review. | Oncol Res | 2026 | https://conductscience.org/library/papers/42984918 | PubMed |
| 42044355 | All you need is fungi: Exploring secondary metabolites as a source of novel amoebicidal agents. | Genet Mol Biol | 2026 | https://conductscience.org/library/papers/42044355 | PubMed |
| 41896658 | The application of nanoparticle-mediated siRNA delivery systems in ovarian cancer. | Cancer Gene Ther | 2026 | https://conductscience.org/library/papers/41896658 | PubMed |
| 41552486 | PI3K/AKT/eNOS Modulation and Angiotensin II Suppression by Dryopteris crassirhizoma Rhizome Extract: Computational and Experimental Evidence. | ACS Omega | 2026 | https://conductscience.org/library/papers/41552486 | PubMed |
| 41357583 | Norrin in cancer: from a promising prognostic biomarker to a novel therapeutic target. | Front Oncol | 2025 | https://conductscience.org/library/papers/41357583 | PubMed |
| 41306662 | Key Nano-Strategies for Cisplatin Resistance in Advancing Anti-Cancer Therapy. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/41306662 | PubMed |
| 40868982 | Tetraarsenic Hexoxide Enhanced the Anticancer Effects of Artemisia annua L. Polyphenols by Inducing Autophagic Cell Death and Apoptosis in Oxalplatin-Resistant HCT116 Colorectal Cancer Cells. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40868982 | PubMed |
| 40402380 | Autophagy mediated immune response regulation and drug resistance in cancer. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/40402380 | PubMed |
| 39902073 | Cynaroside ameliorates TNBS-induced colitis by inhibiting intestinal epithelial cell apoptosis via the PI3K/AKT signalling pathway. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39902073 | PubMed |
| 39854096 | AGDMP1 alleviates insulin resistance by modulating heat shock protein 60-mediated IRS-1/AKT/GLUT4 pathway and adipose inflammation: A potential therapeutic peptide for gestational diabetes mellitus. | FASEB J | 2025 | https://conductscience.org/library/papers/39854096 | PubMed |
| 39350337 | DrugReSC: targeting disease-critical cell subpopulations with single-cell transcriptomic data for drug repurposing in cancer. | Brief Bioinform | 2024 | https://conductscience.org/library/papers/39350337 | PubMed |
| 38732504 | Inhibition of Prostate Cancer Cell Survival and Proliferation by Carnosic Acid Is Associated with Inhibition of Akt and Activation of AMPK Signaling. | Nutrients | 2024 | https://conductscience.org/library/papers/38732504 | PubMed |
| 38275055 | Targeted Mevalonate Pathway and Autophagy in Antitumor Immunotherapy. | Curr Cancer Drug Targets | 2024 | https://conductscience.org/library/papers/38275055 | PubMed |
| 35645792 | Rosmarinic Acid Ameliorates Pulmonary Ischemia/Reperfusion Injury by Activating the PI3K/Akt Signaling Pathway. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35645792 | PubMed |
| 35018228 | The biochemical and clinical implications of phosphatase and tensin homolog deleted on chromosome ten in different cancers. | Am J Cancer Res | 2021 | https://conductscience.org/library/papers/35018228 | PubMed |
| 34415239 | Identification of effective natural PIK3CA H1047R inhibitors by computational study. | Aging (Albany NY) | 2021 | https://conductscience.org/library/papers/34415239 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ATM | 472 | PubTator's text mining | https://conductscience.org/library/genes/472 | NCBI Gene |
| H2AX | 3014 | PubTator's text mining | https://conductscience.org/library/genes/3014 | NCBI Gene |
| PIK3R1 | 5295 | PubTator's text mining | https://conductscience.org/library/genes/5295 | NCBI Gene |
| PRKDC | 5591 | PubTator's text mining | https://conductscience.org/library/genes/5591 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32052028
GET https://conductscience.org/api/papers/v1/32052028/references?page=2